ClinicalTrials.gg
CompletedNCT06964555Updated May 22, 2025

Effect of Intravenous Low-Dose Ketamine Infusion With Intravenous Lignocaine Infusion on Post-Operative Pain in Patients Undergoing Laparoscopic Choleysystectomy Under General Anesthesia

A Phase 4 interventional study of Intravenous Ketamine Infusions and Intravenous lignocaine in Cholelithiases, sponsored by Fazaia Ruth Pfau Medical College. Completed at 1 site in Pakistan. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-05-22.

Sponsored by Fazaia Ruth Pfau Medical College · Phase 4, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 1 year 4 months after the study started (first participant enrolled Jan 2024, registered May 2025).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 4
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 12 studies in Cholelithiasis with a site in Pakistan — 2 open to participants now, 2 under way, none of them phase 3. Cholelithiasis · Pakistan.

Enrollment
5th of 12
100 · median 80
Started
2024
with 2 others
Phase 4
Only one
of the 12
Registered
3rd of 12
by date
Lead sponsor
2 of 12
Fazaia Ruth Pfau Medical College

Among the 12 studies in Cholelithiasis with a site in Pakistan, this one is the 5th largest by enrollment, is one of 3 that started in 2024, is the only one in phase 4, and was the 3rd registered.

Cholelithiasis

192 studies on the registry are indexed under Cholelithiasis; 44 are open to participants now.

Browse Cholelithiasis studies →

Open to participants now

2 of the 12 studies in Cholelithiasis with a site in Pakistan are open now. Recruiting first, the newest first:

All 2 open studies →

A study can be open while its sites in Pakistan have not opened yet or have stopped. Only those recruiting at a site in Pakistan →

Who these studies take

Of the 30 Cholelithiasis studies recruiting now, 20 (67%) set no upper age limit and 7 (23%) stop at 75 or younger; 1 takes children under 18; 7 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 12 studies in Cholelithiasis with a site in Pakistan, or all of them as a file.
02

Study summary

Objective: To determine the effect of low-dose ketamine versus lignocaine on post-operative pain in patients undergoing LC under general anesthesia in a tertiary care hospital.

Sample Selection: Patients of both the gender of age at least 18 years, planned for elective LC with ASA grade I-II were included. Patients with obesity, history of alcohol consumptions, drug abusers, uncontrolled hypertension and diabetics, with chronic pain, allergic to study drugs, having neurological disorders, unable to understand pain scoring system and converted to open LC were excluded.

03

Conditions studied

  • Cholelithiases

Browse trials for

Keywords

  • Cholelithiases
  • Cholecystectomy
  • Laparoscopy
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients of both the gender of age at least 18 years
  • Patients planned for elective LC
  • Patients with I-II were included.

Exclusion criteria

Exclusion Criteria:

  • Patients with obesity,
  • Patients with history of alcohol consumptions, uncontrolled hypertension and diabetics,
  • Drug abusers
  • Patients with chronic pain
  • Patients allergic to study drugs
  • Patients having neurological disorders or unable to understand pain scoring system
  • Patients converted to open LC
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
100 participants (actual)

Study arms

  • Active comparator
    Group L

    Just before the skin incision intravenous lignocaine was given.

    Drug: Intravenous lignocaine

  • Experimental
    Group K

    Just before the skin incision, intravenous ketamine was given

    Drug: Intravenous Ketamine Infusions

Interventions

  • DrugIntravenous Ketamine Infusions

    Ketamine group received ketamine at 0.2mg/kg bolus intravenously followed by ketamine infusion at rate of 0.2mg/kg/hr throughout the surgery.

  • DrugLidocaineStudies of LidocaineLidocaine pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record.

    IV Lignocaine was given at the rate of 1 mg/kg/hr.

06

What researchers measure

Primary outcomes

  1. Post operative Pain

    Pain was assessed using Numeric Rating Scale which is a ten point scoring scale ranging from 0-10 for ranking pain where 0 means no and 10 means worst pain.

    Time frame: 24 hours

Secondary outcomes

  1. Time to rescue analgesia

    Time to rescue analgesia was defined as time point at which patient will be given first rescue analgesia for pain of score more 5 or above.

    Time frame: 24 hours

  2. Wound Closure

    The time between the incision and the wound's closure was used to define the length of the surgery.

    Time frame: End of Surgery

07

Study locations

1 site
  • Fazaia Ruth Pfau Medical College
    Karachi, Sindh 75510, Pakistan
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jan 2024 to primary completion in Nov 2024, 10 months.

How these figures are worked out, and which studies are left out of them.

Registered
May 1, 2025
First posted
May 9, 2025
StartActual
Jan 1, 2024
Primary completionActual
Nov 30, 2024
CompletionActual
Dec 31, 2024
Last update
May 22, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 22, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06964555
Lead sponsor
Fazaia Ruth Pfau Medical College
Responsible party
Syeda Hajrah Rehman (Principal Investigator, Fazaia Ruth Pfau Medical College) — Principal investigator
First posted
May 9, 2025
Start date
Jan 1, 2024
Primary completion
Nov 30, 2024
Completion
Dec 31, 2024
Last update
May 22, 2025

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion